Cardiome Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Cardiome Pharma (CRME) Misses Q3 EPS by 10c
November 13, 2015 7:03 AM ESTCardiome Pharma (NASDAQ: CRME) reported Q3 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $5 million versus the consensus estimate of $7.08 million.
For earnings history and earnings-related data on Cardiome Pharma (CRME) click here.
... More